Personalized auditory cues to improve walking in Parkinson's disease
CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's Disease
This study is testing if personalized sound cues can help people with Parkinson's disease walk better and reduce their chances of falling.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 50 Years to 85 Years |
| Sex | All |
| Sponsor | Northumbria University Academic / other |
| Locations | 2 sites (Newcastle and 1 other locations) |
| Trial ID | NCT06941779 on ClinicalTrials.gov |
What this trial studies
This study investigates how personalized auditory cueing can enhance gait in individuals with Parkinson's Disease (PD). Participants will undergo assessments at the Clinical Gait Laboratory, where they will complete clinical evaluations and walking tests while wearing a smartphone. The goal is to tailor auditory cues to individual needs to improve walking characteristics and reduce fall risk. The study aims to enroll 60 participants who meet specific inclusion criteria related to their PD diagnosis and cognitive function.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with idiopathic Parkinson's Disease who can walk unaided and have a cognitive assessment score of 21 or higher.
Not a fit: Patients with significant cognitive impairment, other neurological disorders, or those unable to comply with the testing protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve mobility and reduce fall risks for patients with Parkinson's Disease.
How similar studies have performed: Previous studies have shown that auditory cueing can effectively improve gait in Parkinson's Disease, suggesting this personalized approach may build on established findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to walk unaided. * Diagnosis of idiopathic PD, as defined by the UK Brain Bank criteria. * Score ≥21/30 on Montreal Cognitive Assessment (MoCA) which is used to classify non-demented PD (PD dementia is \<21/30). Exclusion Criteria: * Non-English speakers * History of stroke, traumatic brain injury or other neurological disorders (other than PD) * Acute lower back or lower extremity pain, peripheral neuropathy, and musculoskeletal disorders that would affect tasks. * Unstable medical condition including cardio-vascular instability in the past 6 months * Unable to comply with the testing protocol or currently participating in another interfering research project
Where this trial is running
Newcastle and 1 other locations
- Northumbria University — Newcastle, United Kingdom (Recruiting)
- North Tyneside General Hospital — North Shields, United Kingdom (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.